Examkin

All practice questions

4736 questions

All types4,736Multiple choice2,413Multiple select567Numeric127Matching858Ordering771
Question 641Question →

A series of hospitalized patients develop distinct drug-induced immunologic and inflammatory reactions. Match each specific clinical presentation to its precise underlying foundational pathophysiologic mechanism.

Click a left item, then click its matching right item

Items

A 45-year-old man develops fever, diffuse maculopapular rash, and progressive respiratory distress one week after initiating abacavir for HIV infection.
A 60-year-old woman develops new-onset myalgias, arthralgias, and pleuritic chest pain after six months of hydralazine therapy, with a homogeneously positive ANA.
A 35-year-old man receiving intravenous vancomycin for bacteremia rapidly develops marked erythema and pruritus of the face, neck, and upper torso during the infusion.
A 70-year-old man on a proton pump inhibitor develops progressive acute kidney injury, sterile pyuria with eosinophils, and a mild systemic rash.

Matches

Show answer & explanation

Answer

Abacavir hypersensitivity matches with HLA-binding alteration. Hydralazine-induced lupus matches with DNA methylation inhibition. Vancomycin flushing matches with direct mast cell activation. Acute interstitial nephritis matches with hapten-mediated delayed T-cell response.
Each specific clinical scenario reflects a unique, high-yield mechanism of drug-induced immunopathology. Abacavir strictly relies on structural modification of the HLA-B*57:01 groove. Hydralazine induces lupus via epigenetic disruption (DNA hypomethylation) causing loss of central T-cell tolerance. Vancomycin causes direct pharmacologic (non-IgE) mast cell degranulation. Proton pump inhibitors cause AIN by acting as haptens that incite a Type IV cell-mediated response in the kidney.

Step-by-Step Solution

1
Analyze the abacavir vignette.
Identified as abacavir hypersensitivity syndrome. This requires screening for HLA-B*57:01 because the drug directly alters the HLA-binding groove, activating CD8+ T cells.
Recognizing the exact molecular pathogenesis of severe abacavir toxicity is essential for preventing potentially fatal rechallenge.
2
Analyze the hydralazine vignette.
Identified as drug-induced lupus erythematosus (DILE). Hydralazine acts via inhibition of DNA methylation, leading to anti-histone antibody formation.
Differentiating the mechanism of DILE from idiopathic SLE highlights why specific autoantibodies (anti-histone vs. anti-dsDNA) are formed.
3
Analyze the vancomycin vignette.
Identified as vancomycin flushing syndrome. This is an anaphylactoid reaction driven by direct, IgE-independent mast cell degranulation.
Understanding it is not a true IgE-mediated allergy dictates management (slowing the infusion rate rather than permanent contraindication).
4
Analyze the proton pump inhibitor vignette.
Identified as acute interstitial nephritis (AIN). This is classically a Type IV hypersensitivity where the drug acts as a hapten in the renal interstitium.
AIN requires recognition of a delayed, cell-mediated attack on haptenized renal proteins to justify the use of systemic corticosteroids if drug cessation is insufficient.

Key Concept

Foundational mechanisms of drug-induced immunopathologies (Type IV hypersensitivity, altered MHC presentation, haptenization, and direct mast cell activation).
Question 642Question →

A 45-year-old man presents to the clinic with acute-onset lower back pain that radiates down the posterior right thigh and calf to the lateral foot. The pain began three days ago after he helped a friend move heavy furniture. He denies fever, weight loss, urinary incontinence, or saddle anesthesia. Vital signs are within normal limits. On physical examination, passive elevation of the patient's symptomatic right leg to 40 degrees produces sharp, shooting pain down the posterior right leg. Furthermore, passive elevation of his asymptomatic left leg to 45 degrees reproduces the exact same shooting pain down the right leg. Neurologic examination shows normal perianal sensation, 5/5 motor strength in the lower extremities, and intact symmetric deep tendon reflexes. A complete blood count drawn for a routine wellness check two days prior to symptom onset was notable only for an isolated leukocyte count of 11,200/mm³. Based on the interpretation of these physical examination findings, which of the following is the most appropriate next step in establishing the diagnosis and management?

Show answer & explanation

Answer: Recognize the findings as highly specific for lumbar nerve root compression and initiate a trial of conservative therapy

Answer

Recognize the findings as highly specific for lumbar nerve root compression and initiate a trial of conservative therapy.
The patient exhibits a positive straight leg raise test on the affected side and a positive crossed straight leg raise test on the asymptomatic side. While the standard straight leg raise is highly sensitive for L4-S1 nerve root compression, the crossed straight leg raise is highly specific (approximately 90%) for a herniated nucleus pulposus. Because the patient lacks 'red flag' findings (such as profound motor deficits, saddle anesthesia, bowel or bladder dysfunction, or fever), the physical examination is sufficient to establish a working diagnosis of acute lumbosacral radiculopathy. Current guidelines mandate a 4 to 6-week trial of conservative management before considering advanced imaging.

Step-by-Step Solution

1
Analyze the physical examination findings.
The patient has a positive straight leg raise (sensitive for nerve root compression) and a positive crossed straight leg raise (highly specific for a herniated nucleus pulposus causing nerve root compression).
Accurate interpretation of these bedside maneuvers is essential to formulate the working diagnosis of lumbosacral radiculopathy.
2
Evaluate the clinical context for 'red flag' symptoms.
The patient has normal perianal sensation, intact motor strength, no fever, and normal bowel/bladder function, ruling out cauda equina syndrome or serious spinal infection.
The presence or absence of red flags dictates whether urgent imaging and intervention are required.
3
Determine the standard of care for the established clinical diagnosis.
Acute lumbosacral radiculopathy without red flags is managed with a 4 to 6-week trial of conservative therapy (NSAIDs, activity modification) without initial advanced imaging.
Immediate imaging does not alter early management and may reveal incidental abnormalities, leading to unnecessary invasive procedures.

Key Concept

The crossed straight leg raise test is highly specific for lumbar nerve root compression; however, definitive physical exam signs of radiculopathy do not mandate early imaging in the absence of 'red flag' clinical symptoms.
Question 643Question →

A 62-year-old man undergoes emergent abdominal aortic aneurysm repair complicated by massive intraoperative hemorrhage. He experiences a 45-minute period of profound hypotension. Despite aggressive fluid resuscitation and blood transfusions, his serum creatinine rises from 0.9 mg/dL to 3.4 mg/dL over the next 48 hours, and urinalysis reveals muddy brown granular casts, indicating acute tubular necrosis. The pathogenesis of this condition involves a predictable cascade of cellular injury resulting from severe ischemia. Arrange the following subcellular pathophysiologic events in the chronological order in which they occurred within this patient's affected proximal tubular epithelial cells, from the initial ischemic insult to ultimate cell death.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

Decrease in oxidative phosphorylation -> Failure of Na+/K+-ATPase -> Cellular swelling -> Massive calcium influx -> Irreversible membrane rupture.
Ischemic injury follows a predictable subcellular cascade. Hypoxia primarily halts mitochondrial oxidative phosphorylation, causing rapid ATP depletion. This energy deficit immediately disables the Na+/K+-ATPase pump, resulting in an influx of sodium and water, which manifests as cellular swelling and ribosome detachment (reversible changes). As ischemia persists, cellular calcium pumps also fail, leading to a massive cytosolic calcium influx. This excess calcium activates endogenous phospholipases, proteases, and endonucleases, which dismantle the cytoskeleton, nuclear chromatin, and lipid bilayer. The destruction of these structural components ultimately leads to irreversible plasma membrane rupture and the spillage of intracellular contents, defining coagulative necrosis.

Step-by-Step Solution

1
Identify the primary insult
Profound hypotension caused severe renal hypoperfusion and ischemia.
Establishing the type of injury determines the specific cellular cascade, which in this case is hypoxic-ischemic injury.
2
Determine the immediate biochemical consequence of ischemia
Loss of oxygen halts mitochondrial oxidative phosphorylation, leading to rapid ATP depletion.
Oxygen is the terminal electron acceptor in the electron transport chain; without it, ATP production ceases rapidly.
3
Identify the downstream effects of ATP depletion
Failure of energy-dependent pumps (Na+/K+-ATPase) occurs, leading to intracellular sodium accumulation and subsequent cellular swelling.
The Na+/K+-ATPase normally maintains ion gradients; its failure causes osmotic shifts leading to early, reversible cellular changes.
4
Determine the transition to irreversible injury
Severe membrane damage allows massive calcium influx, which activates degradative enzymes, culminating in plasma membrane rupture.
High intracellular calcium activates phospholipases and proteases that destroy the cell membrane, marking the hallmark of irreversible coagulative necrosis.

Key Concept

The chronological sequence of hypoxic-ischemic cellular injury progresses from ATP depletion to pump failure, reversible cellular swelling, calcium influx, and finally irreversible membrane rupture.
Question 644Question →

A 34-year-old woman comes to the clinic for follow-up evaluation of right leg pain and swelling. She has a history of an unprovoked left pulmonary embolism six months ago, for which she has been taking rivaroxaban. Her symptoms had completely resolved until three days ago, when she developed worsening right calf pain. Two weeks ago, she was diagnosed with active pulmonary tuberculosis and began treatment with a four-drug regimen containing rifampin, isoniazid, pyrazinamide, and ethambutol. Vital signs are within normal limits. Physical examination shows a swollen, erythematous, and tender right calf. A venous duplex ultrasound confirms a new acute deep vein thrombosis in the right popliteal vein. Which of the following pharmacokinetic principles best explains this patient's current presentation?

Show answer & explanation

Answer: Accelerated systemic elimination via hepatic enzyme induction

Answer

Accelerated systemic elimination via hepatic enzyme induction
The correct answer identifies that the patient's recurrent thrombosis is due to a well-known pharmacokinetic drug interaction. Rifampin is a potent inducer of the cytochrome P450 system (particularly CYP3A4) and the P-glycoprotein (P-gp) efflux transporter. Rivaroxaban relies heavily on CYP3A4 for metabolism and P-gp for excretion. The induction of these pathways markedly accelerates the clearance of rivaroxaban, dropping its plasma concentration below the therapeutic threshold and leaving the patient vulnerable to recurrent thromboembolic events.

Step-by-Step Solution

1
Analyze the patient's clinical presentation.
The patient developed a new deep vein thrombosis while supposedly fully anticoagulated on rivaroxaban.
Identifying a therapeutic failure (recurrent thrombosis) establishes that the anticoagulant effect is currently subtherapeutic.
2
Identify any recent changes to the patient's medication regimen.
The patient recently started a four-drug regimen for active tuberculosis, which includes rifampin.
New medications are the most common cause of sudden pharmacokinetic shifts leading to loss of efficacy.
3
Recall the pharmacokinetic properties of the involved medications.
Rivaroxaban is metabolized by CYP3A4 and is a substrate for the P-glycoprotein (P-gp) efflux transporter. Rifampin is a potent inducer of both CYP3A4 and P-gp.
Understanding the specific metabolic pathways allows for the identification of the exact drug-drug interaction mechanism.
4
Determine the clinical consequence of this interaction.
Induction of CYP3A4 and P-gp significantly accelerates the clearance of rivaroxaban, leading to subtherapeutic drug concentrations and subsequent clot formation.
This confirms that accelerated systemic elimination is the definitive cause of the patient's presentation.

Key Concept

Rifampin is a potent inducer of cytochrome P450 enzymes (specifically CYP3A4) and P-glycoprotein. Co-administration with direct oral anticoagulants (DOACs) like rivaroxaban accelerates their clearance, resulting in subtherapeutic levels and an increased risk of thromboembolism.
Question 645Question →

A 48-year-old man is evaluated in the endocrinology clinic for a 4-month history of progressive central weight gain, easy bruising, and proximal muscle weakness. He reports significant difficulty climbing stairs. His medical history includes asthma and HIV. His medications include a fluticasone-salmeterol inhaler, which he has used at a stable dose for three years, and an antiretroviral regimen consisting of bictegravir, emtricitabine, and tenofovir alafenamide, which has kept his viral load undetectable for five years. He explicitly denies using oral, topical, or injectable corticosteroids. His blood pressure is 158/96158/96 mmHg. Physical examination reveals a dorsocervical fat pad, facial plethora, and wide violaceous striae on his abdomen.

Laboratory studies show:
Morning serum cortisol: 0.80.8 μ\mu g/dL (Normal: 5−255 - 25 μ\mu g/dL)
Plasma ACTH: <5< 5 pg/mL (Normal: 10−6010 - 60 pg/mL)

Which of the following elements of his recent medical history most likely explains his clinical presentation and laboratory findings?

Show answer & explanation

Answer: Initiation of oral therapy for onychomycosis

Answer

The correct answer is the initiation of oral therapy for onychomycosis, which introduces a potent CYP3A4 inhibitor that interacts with his inhaled corticosteroid.
The correct answer identifies the initiation of oral therapy for onychomycosis as the trigger for this patient's condition. This patient presents with classic Cushing syndrome (central adiposity, violaceous striae, proximal weakness) coupled with profoundly low endogenous cortisol and ACTH levels. This laboratory pattern definitively points to exogenous glucocorticoid administration suppressing the hypothalamic-pituitary-adrenal (HPA) axis. Although the patient denies taking systemic steroids, he is on a fluticasone inhaler. Fluticasone has high glucocorticoid receptor affinity but typically low systemic bioavailability due to extensive first-pass metabolism by hepatic and intestinal cytochrome P450 3A4 (CYP3A4). Itraconazole, a common oral treatment for onychomycosis, is a potent CYP3A4 inhibitor. Taking these medications concurrently leads to massive systemic accumulation of fluticasone, resulting in iatrogenic Cushing syndrome and severe secondary adrenal suppression. Careful review of the medical history for seemingly unrelated recent prescriptions is critical for diagnosing complex pharmacological interactions.

Step-by-Step Solution

1
Identify the clinical syndrome.
The patient exhibits classic signs of Cushing syndrome (weight gain, proximal weakness, violaceous striae, facial plethora, hypertension).
Recognizing the syndrome guides the interpretation of the subsequent endocrinologic laboratory workup.
2
Interpret the laboratory findings (cortisol and ACTH).
Both morning serum cortisol and plasma ACTH are profoundly suppressed.
Low ACTH with low endogenous cortisol indicates that the hypothalamic-pituitary-adrenal (HPA) axis is suppressed by an exogenous source of glucocorticoids. Endogenous Cushing syndrome (e.g., pituitary adenoma, adrenal tumor) would present with elevated cortisol.
3
Correlate the exogenous steroid source with the medication history.
The patient denies oral/injectable steroids but is taking inhaled fluticasone.
Standard doses of inhaled fluticasone rarely cause severe systemic Cushing syndrome unless its first-pass metabolism is impaired.
4
Evaluate for pharmacokinetic drug-drug interactions.
Fluticasone is metabolized extensively by the hepatic and intestinal enzyme CYP3A4.
If CYP3A4 is inhibited, systemic absorption and accumulation of fluticasone skyrocket, leading to iatrogenic Cushing syndrome.
5
Identify the source of CYP3A4 inhibition in the history.
Oral therapy for onychomycosis (e.g., itraconazole) is a classic, potent inhibitor of CYP3A4.
Adding itraconazole to a patient on fluticasone precipitates sudden, severe exogenous hypercortisolism.

Key Concept

Iatrogenic Cushing syndrome with secondary adrenal suppression can be precipitated by drug-drug interactions, classically when a potent CYP3A4 inhibitor (like itraconazole) is prescribed alongside an inhaled corticosteroid (like fluticasone).
Question 646Question →

An 80-kg80 \text{-kg}, 60-year-old60 \text{-year-old} male patient is undergoing treatment in the intensive care unit for severe hospital-acquired pneumonia. The clinical team initiates continuous intravenous therapy with a novel narrow-therapeutic-index antimicrobial agent. The pharmacokinetic profile of this drug in the patient indicates a volume of distribution of 0.5 L/kg0.5 \text{ L/kg} and a systemic clearance of 0.04 L/hr/kg0.04 \text{ L/hr/kg}. The desired steady-state plasma concentration of the medication is 20 mg/L20 \text{ mg/L}.

To maintain this target steady-state concentration, what should be the continuous intravenous infusion rate in mg/hr?

Show answer & explanation

Answer: 64

Answer

64
To maintain a steady-state concentration of a drug, the rate of drug administration must equal the rate of drug elimination. The elimination rate is calculated as the product of the total systemic clearance and the target steady-state concentration. First, the total clearance is found by multiplying the weight-adjusted clearance by the patient's weight (0.04 L/hr/kg×80 kg=3.2 L/hr0.04 \text{ L/hr/kg} \times 80 \text{ kg} = 3.2 \text{ L/hr}). Then, the maintenance infusion rate is calculated by multiplying the total clearance by the target concentration (3.2 L/hr×20 mg/L=64 mg/hr3.2 \text{ L/hr} \times 20 \text{ mg/L} = 64 \text{ mg/hr}).

Step-by-Step Solution

1
Calculate the patient's total systemic clearance.
0.04 L/hr/kg×80 kg=3.2 L/hr0.04 \text{ L/hr/kg} \times 80 \text{ kg} = 3.2 \text{ L/hr}
Clearance is provided on a per-kilogram basis and must be scaled to the patient's actual body weight to determine the total drug elimination rate.
2
Calculate the continuous maintenance infusion rate.
3.2 L/hr×20 mg/L=64 mg/hr3.2 \text{ L/hr} \times 20 \text{ mg/L} = 64 \text{ mg/hr}
The maintenance dose rate is the product of clearance and the target steady-state concentration.

Key Concept

Maintenance dose rate is determined solely by the drug's clearance and the desired steady-state plasma concentration.
Question 647Question →

A 67-year-old man with a 40-pack-year smoking history and severe chronic obstructive pulmonary disease presents to the clinic complaining of increasing lower extremity swelling, progressive fatigue, and abdominal fullness over the past month. He denies paroxysmal nocturnal dyspnea, orthopnea, or chest pain. Vital signs are temperature 37.1°C (98.8°F), blood pressure 118/76 mmHg, pulse 94/min, and respiratory rate 18/min. Pulse oximetry shows 89% on room air. The physician suspects cor pulmonale (isolated right-sided heart failure secondary to pulmonary disease). Which of the following physical examination findings are most consistent with this specific diagnosis? (Select exactly 2 options)

Select all that apply

Show answer & explanation

Answer: A palpable left parasternal lift; A tender, pulsatile liver edge

Answer

The correct physical examination findings are a palpable left parasternal lift and a tender, pulsatile liver edge.
Cor pulmonale is defined as right ventricular hypertrophy and eventual right heart failure resulting from primary pulmonary disease (such as severe chronic obstructive pulmonary disease). As the right ventricle hypertrophies against elevated pulmonary artery pressures, it generates a palpable left parasternal lift (or heave). As the ventricle subsequently dilates and fails, the tricuspid annulus stretches, leading to secondary tricuspid regurgitation. The resulting retrograde transmission of venous pressure creates a tender, pulsatile liver edge. Both findings specifically localize the pathology to the right side of the heart, ruling out left ventricular involvement.

Step-by-Step Solution

1
Evaluate the patient's symptoms and vital signs.
The patient has signs of fluid overload (edema, ascites) and a history of severe COPD, without symptoms of left heart failure (orthopnea, paroxysmal nocturnal dyspnea).
To determine the most likely primary pathology, which is cor pulmonale (isolated right heart failure).
2
Identify physical exam findings specific to right ventricular hypertrophy.
A left parasternal lift (heave) is palpable.
The anterior anatomical position of the hypertrophied right ventricle causes a palpable impulse along the left sternal border during systole.
3
Identify physical exam findings specific to right ventricular failure and backward systemic congestion.
A tender, pulsatile liver edge is palpable.
Right ventricular dilation leads to secondary tricuspid regurgitation, transmitting right ventricular systolic pressure retrograde into the hepatic veins.

Key Concept

Differentiating the physical examination findings of isolated right-sided heart failure (cor pulmonale) from left-sided or biventricular heart failure.
Question 648Question →

A 34-year-old industrial worker is brought to the emergency department by emergency medical services after his coworkers found him acutely confused and vomiting in a storage room. His coworkers report that for the past several hours, he had been cleaning old, degraded machinery in a poorly ventilated space using a previously restricted halogenated hydrocarbon solvent (carbon tetrachloride). He accidentally spilled a large quantity of the solvent on his clothing and inhaled the fumes. On arrival, his blood pressure is 110/70 mmHg, and his pulse is 105/min. Physical examination is notable for scleral icterus, right upper quadrant abdominal tenderness, and asterixis. Laboratory studies demonstrate an aspartate aminotransferase (AST) of 4,200 U/L and an alanine aminotransferase (ALT) of 4,500 U/L. Which of the following best describes the initial subcellular mechanism responsible for this patient's acute hepatic injury?

Show answer & explanation

Answer: Conversion of the molecule by the smooth endoplasmic reticulum into a highly reactive free radical

Answer

Conversion of the molecule by the smooth endoplasmic reticulum into a highly reactive free radical
Carbon tetrachloride (CCl4CCl_4) is a classic industrial hepatotoxin. Once it enters the body, it is delivered to the liver where the cytochrome P450 oxidase system—abundant in the smooth endoplasmic reticulum of hepatocytes—metabolizes it. This process generates the trichloromethyl free radical (CCl3∙CCl_3^\bullet). This highly reactive oxygen species immediately attacks the lipid-rich cellular and organelle membranes, a process known as lipid peroxidation. This causes the rough endoplasmic reticulum to swell and ribosomes to detach, leading to decreased protein synthesis (such as apolipoproteins, resulting in fatty change). Ultimately, the overwhelming membrane damage causes massive calcium influx, mitochondrial failure, and centrilobular necrosis, as evidenced by the extreme elevations in AST and ALT.

Step-by-Step Solution

1
Identify the patient's primary clinical presentation and exposure.
The patient has massive acute hepatocellular injury (AST and ALT > 4,000 U/L) following a large exposure to carbon tetrachloride (CCl4CCl_4).
Recognizing the specific toxicological agent is required to determine the precise pathophysiology of the cell injury.
2
Determine how the specific toxin interacts with the target organ's cellular machinery.
Carbon tetrachloride is rapidly absorbed and transported to the liver, where it is metabolized by the cytochrome P450 mixed-function oxidase system located in the smooth endoplasmic reticulum.
Toxins often require metabolic activation to cause tissue-specific damage.
3
Identify the downstream cellular consequences of this interaction.
The CYP450 system converts CCl4CCl_4 into the trichloromethyl free radical (CCl3∙CCl_3^\bullet), which initiates a catastrophic chain reaction of lipid peroxidation, leading to structural membrane breakdown and eventual centrilobular necrosis.
Understanding the transition from chemical interaction to morphological cell death defines the foundational mechanism of this injury.

Key Concept

The hallmark of carbon tetrachloride hepatotoxicity is its metabolism by the hepatic cytochrome P450 system into a highly reactive free radical, which causes devastating lipid peroxidation and subsequent cellular necrosis.
Question 649Question →

A 58-year-old man is hospitalized for pyelonephritis and bacteremia. Initial blood cultures grow *Enterobacter cloacae*. Antibiotic susceptibility testing indicates that the isolate is susceptible to ceftriaxone, and therapy with this agent is initiated. The patient initially improves, but on day 5 of hospitalization, he develops recurrent fever, tachycardia, and a rising leukocyte count. Repeat blood cultures grow *Enterobacter cloacae* that is now resistant to ceftriaxone, ceftazidime, and piperacillin-tazobactam, but remains susceptible to meropenem and amikacin. Which of the following best describes the molecular mechanism responsible for the pathogen's new resistance profile?

Show answer & explanation

Answer: Derepression of a chromosomal gene encoding an enzyme that hydrolyzes the beta-lactam ring

Answer

Derepression of a chromosomal gene encoding an enzyme that hydrolyzes the beta-lactam ring
The correct answer describes the derepression of the chromosomal AmpC beta-lactamase gene. Certain Gram-negative bacilli, often remembered by the mnemonic 'SPACE' or 'ESPM' (Enterobacter, Serratia, Pseudomonas, Morganella), harbor an inducible, chromosomal AmpC beta-lactamase gene. When these organisms are exposed to certain beta-lactam antibiotics like ceftriaxone, a mutant subpopulation that constitutively hyperproduces (derepresses) the AmpC enzyme is selected for. This results in clinical failure and widespread beta-lactam resistance, including resistance to third-generation cephalosporins and beta-lactamase inhibitors like piperacillin-tazobactam. Carbapenems, such as meropenem, are stable against AmpC hydrolysis and remain the treatment of choice for severe infections with these organisms.

Step-by-Step Solution

1
Analyze the clinical scenario and microbiology data
The patient has an Enterobacter cloacae infection that developed rapid resistance to 3rd-generation cephalosporins and beta-lactamase inhibitors while on ceftriaxone therapy, but retained susceptibility to carbapenems.
To identify the typical resistance pattern of the isolated organism.
2
Identify the primary resistance mechanism of the organism
Enterobacter cloacae has an inducible, chromosomally mediated AmpC beta-lactamase.
Matching the pathogen to its intrinsic genetic resistance capabilities.
3
Correlate the mechanism with the clinical presentation
Exposure to ceftriaxone selected for a derepressed mutant subpopulation that constitutively hyperproduces AmpC, explaining the new resistance to ceftriaxone and piperacillin-tazobactam.
To confirm that the resistance mechanism aligns with the drug susceptibilities provided.

Key Concept

Organisms with inducible chromosomal AmpC beta-lactamases (such as Enterobacter, Serratia, and Citrobacter) can rapidly develop resistance to third-generation cephalosporins during therapy due to derepression of the AmpC gene.
Question 650Question →

A 38-year-old woman is evaluated in the ambulatory clinic for a 6-month history of progressive weight gain, easy bruising, and worsening fatigue. She also reports that her menstrual periods have become irregular. Her blood pressure is 158/96 mmHg. Physical examination reveals central adiposity, facial plethora, a dorsocervical fat pad, and wide, violaceous striae on the lower abdomen. She takes no medications and has no history of exogenous glucocorticoid use. Which of the following is the most appropriate next step in the diagnostic workup?

Show answer & explanation

Answer: Overnight low-dose dexamethasone suppression test

Answer

Overnight low-dose dexamethasone suppression test
The patient presents with classic clinical features of Cushing syndrome. The diagnostic workup for Cushing syndrome must follow a strict sequence to avoid false-positive results. The first step is always to confirm the presence of endogenous hypercortisolism. Acceptable first-line screening tests include an overnight low-dose dexamethasone suppression test, a 24-hour urine free cortisol measurement, or a late-night salivary cortisol test. Only after hypercortisolism is biochemically confirmed should the clinician proceed to determine the etiology.

Step-by-Step Solution

1
Identify the clinical syndrome presented by the patient.
The patient has classical signs of Cushing syndrome, including central obesity, facial plethora, dorsocervical fat pad, and violaceous striae.
Recognizing the constellation of symptoms directs the specific diagnostic algorithm.
2
Determine the first step in the diagnostic sequence for this condition.
The initial step is to establish the presence of endogenous hypercortisolism using a highly sensitive screening test.
Confirmatory testing and localization must wait until the biochemical presence of the disease is established to avoid false positives.
3
Select the appropriate screening test from the available options.
An overnight low-dose dexamethasone suppression test is selected.
This is one of the three standard first-line screening tests for Cushing syndrome.

Key Concept

The initial diagnostic step for suspected Cushing syndrome requires confirming hypercortisolism with a first-line screening test (overnight low-dose dexamethasone suppression test, 24-hour urine free cortisol, or late-night salivary cortisol) before assessing ACTH levels or performing imaging.
Question 651Question →

A 35-year-old woman presents to the clinic with a 6-month history of progressive weight gain, proximal muscle weakness, and easy bruising. Physical examination reveals a blood pressure of 155/95 mmHg, facial plethora, central adiposity with violaceous striae, and prominent supraclavicular fat pads. The physician suspects an endogenous hypercortisolism syndrome. Assuming each subsequent test result confirms the need for further diagnostic workup, arrange the following laboratory investigations in the most appropriate chronological order to establish the precise etiology of this patient's condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence for evaluating suspected Cushing syndrome is: Late-night salivary cortisol assay, followed by Plasma ACTH level, then High-dose dexamethasone suppression test, and finally Bilateral inferior petrosal sinus sampling.
The sequence follows the standard diagnostic algorithm for Cushing syndrome: 1) Confirm hypercortisolism (Late-night salivary cortisol), 2) Establish ACTH dependency (Plasma ACTH), 3) Non-invasive localization of ACTH-dependent disease (High-dose dexamethasone test), and 4) Invasive localization if non-invasive tests are equivocal (IPSS).

Step-by-Step Solution

1
Screen for pathological hypercortisolism.
Perform a late-night salivary cortisol assay (or 24-hour urine free cortisol, or low-dose dexamethasone suppression test).
The diagnosis of hypercortisolism must be definitively established before attempting to localize the source of the excess cortisol.
2
Determine if the hypercortisolism is ACTH-dependent or ACTH-independent.
Measure plasma ACTH levels.
A suppressed ACTH level indicates an adrenal source (independent), whereas a normal or elevated ACTH level indicates a pituitary or ectopic source (dependent).
3
Differentiate between pituitary and ectopic sources of ACTH using non-invasive methods.
Perform a high-dose (8-mg) dexamethasone suppression test.
Pituitary adenomas typically retain some negative feedback mechanisms and will suppress cortisol production at high doses, while ectopic tumors (e.g., small cell lung cancer) typically do not.
4
Confirm the ACTH source if non-invasive tests or imaging are inconclusive.
Perform bilateral inferior petrosal sinus sampling (IPSS).
This is the most accurate, invasive method to definitively differentiate pituitary from ectopic ACTH production by comparing central (petrosal) to peripheral ACTH concentration ratios.

Key Concept

The diagnostic algorithm for Cushing syndrome proceeds in a strict sequential order: establish the presence of hypercortisolism, determine ACTH dependence, and subsequently localize the ACTH source via non-invasive and then invasive testing if needed.
Estimated Time:1m 30s
Question 652Question →

Review the following four clinical scenarios involving complex hemodynamic or coagulation abnormalities. Pair each patient's presentation with the primary molecular or physiologic mechanism responsible for their condition.

Click a left item, then click its matching right item

Items

A 3737-year-old man presenting with altered mental status, fever, petechiae, a platelet count of 18,000/μL18,000/\mu\text{L}, and normal prothrombin time and activated partial thromboplastin time.
A 6565-year-old woman with urosepsis who develops diffuse mucosal oozing, a platelet count of 25,000/μL25,000/\mu\text{L}, prolonged prothrombin time, prolonged activated partial thromboplastin time, and a plasma fibrinogen level of 80 mg/dL80 \text{ mg/dL}.
A 5858-year-old man who develops painful, violaceous, necrotic skin lesions on his thighs three days after initiating an oral medication for an acute pulmonary embolism.
A 2929-year-old woman with a history of recurrent mid-trimester miscarriages presenting with an unprovoked deep venous thrombosis and an isolated, prolonged activated partial thromboplastin time.

Matches

Show answer & explanation

Answer

The 37-year-old man with normal coagulation times matches with metalloproteinase inhibition (TTP). The 65-year-old woman with prolonged coagulation times and low fibrinogen matches with systemic activation of the coagulation cascade (DIC). The 58-year-old man with necrotic skin lesions matches with rapid depletion of a vitamin K-dependent endogenous anticoagulant (Warfarin-induced skin necrosis). The 29-year-old woman with an isolated prolonged aPTT matches with autoantibodies targeting phospholipid-binding proteins (Antiphospholipid syndrome).
Each clinical vignette provides classic diagnostic clues for a specific coagulation disorder, which must be paired with its underlying mechanism. TTP is mediated by ADAMTS13 deficiency. DIC is a consumptive coagulopathy triggered by systemic inflammation and tissue factor. Warfarin necrosis is driven by rapid protein C depletion. APLS involves autoantibodies causing in vivo thrombosis and paradoxical in vitro aPTT prolongation.

Step-by-Step Solution

1
Analyze the presentation of the 37-year-old man with altered mental status, fever, and severe thrombocytopenia.
Identify the diagnosis as Thrombotic Thrombocytopenic Purpura (TTP), which matches with autoantibody-mediated inhibition of the ADAMTS13 metalloproteinase.
The combination of severe thrombocytopenia, microangiopathic changes, and neurologic symptoms with normal PT and aPTT strongly distinguishes TTP from consumptive coagulopathies.
2
Evaluate the 65-year-old woman with urosepsis, diffuse oozing, thrombocytopenia, and hypofibrinogenemia.
Identify the diagnosis as Disseminated Intravascular Coagulation (DIC), which matches with systemic activation of the coagulation cascade by tissue factor.
Sepsis triggers massive tissue factor release, causing widespread microvascular thrombosis that consumes platelets and coagulation factors, leading to prolonged PT/aPTT and low fibrinogen.
3
Assess the 58-year-old man with necrotic skin lesions starting three days after initiating oral medication for a pulmonary embolism.
Identify the diagnosis as Warfarin-induced skin necrosis, which matches with the rapid depletion of a vitamin K-dependent endogenous anticoagulant.
Warfarin initially depletes Protein C (an endogenous anticoagulant with a short half-life) faster than procoagulant factors, creating a transient, severe hypercoagulable state.
4
Review the 29-year-old woman with recurrent miscarriages, venous thrombosis, and an isolated prolonged aPTT.
Identify the diagnosis as Antiphospholipid Syndrome (APLS), which matches with autoantibodies targeting phospholipid-binding proteins.
The lupus anticoagulant in APLS causes an in vitro aPTT prolongation by interfering with assay phospholipids, while paradoxically promoting severe in vivo hypercoagulability.

Key Concept

Differentiating consumptive, autoimmune, and pharmacologically-induced coagulopathies requires correlating the clinical context (e.g., sepsis, medication initiation) with specific laboratory patterns (e.g., normal versus prolonged PT/aPTT, fibrinogen levels).
Question 653Question →

Match each patient's clinical and histopathologic presentation with the primary molecular mechanism driving their underlying neoplastic process.

Click a left item, then click its matching right item

Items

A 65-year-old man presents with generalized lymphadenopathy. Biopsy shows an aggressive proliferation of small to medium-sized CD5-positive, CD23-negative B cells.
A 58-year-old woman with a history of painless, waxing and waning lymphadenopathy undergoes a biopsy showing nodular aggregates of neoplastic cells lacking tingible body macrophages.
A 48-year-old man presents with early satiety and massive splenomegaly. Labs show a leukocyte count of 85,000/mm385,000/\text{mm}^3 with a full spectrum of granulocytic differentiation and low leukocyte alkaline phosphatase.
A 25-year-old man presents with a rapidly expanding neck mass. Biopsy reveals uniform, medium-sized lymphoid cells with numerous mitotic figures and interspersed macrophages containing apoptotic debris.

Matches

Show answer & explanation

Answer

The correct pairings match Mantle cell lymphoma with cell cycle progression (Cyclin D1); Follicular lymphoma with inhibition of apoptosis (BCL-2); Chronic myeloid leukemia with activated tyrosine kinase signaling (BCR-ABL); and Burkitt lymphoma with transcription factor overexpression (c-Myc).
Each correct pairing accurately links the diagnostic clinical/pathologic features of a hematologic malignancy to the precise intracellular mechanism of its primary oncogenic driver (Cyclin D1 for Mantle Cell, BCL-2 for Follicular, BCR-ABL for CML, and c-Myc for Burkitt).

Step-by-Step Solution

1
Analyze each clinical vignette to identify the specific hematologic malignancy based on demographics, clinical behavior, and histopathologic or laboratory findings.
Identified Mantle cell lymphoma, Follicular lymphoma, Chronic myeloid leukemia, and Burkitt lymphoma.
Accurate pathologic diagnosis is required before the underlying molecular driver can be identified.
2
Recall the characteristic chromosomal translocation associated with each identified malignancy.
Mantle cell is t(11;14); Follicular is t(14;18); CML is t(9;22); Burkitt is t(8;14).
Chromosomal translocations are the initiating events in these specific neoplastic processes.
3
Connect the specific gene product of each translocation to its functional role in the cell to find the correct match.
t(11;14) = Cyclin D1 (G1-to-S phase); t(14;18) = BCL-2 (anti-apoptotic mitochondrial protein); t(9;22) = BCR-ABL (tyrosine kinase); t(8;14) = c-Myc (transcription factor).
Understanding the downstream molecular consequence is essential for correlating the disease with its targeted cellular mechanism.

Key Concept

Molecular pathogenesis of hematologic malignancies via specific chromosomal translocations.
Question 654Question →

A 68-year-old woman is admitted to the hospital with a 2-day history of acute-onset right leg pain and swelling. She has a history of type 2 diabetes mellitus, hypertension, and advanced chronic kidney disease. Her current medications include amlodipine, lisinopril, and insulin glargine. Vital signs are temperature 37.1°C (98.8°F), blood pressure 142/86 mm Hg, heart rate 88/min, and respiratory rate 16/min. Physical examination reveals pitting edema, erythema, and tenderness of the right lower extremity extending to the mid-thigh. Laboratory studies show:

Serum creatinine: 4.8 mg/dL (Estimated glomerular filtration rate: 11 mL/min/1.73 m²)
Platelet count: 180,000/mm³
Prothrombin time: 11 seconds
Partial thromboplastin time: 28 seconds

Compression ultrasonography of the right lower extremity confirms a deep vein thrombosis in the right femoral vein. The decision is made to initiate immediate systemic anticoagulation. Which of the following is the most appropriate initial pharmacotherapy for this patient?

Show answer & explanation

Answer: Intravenous unfractionated heparin

Answer

Intravenous unfractionated heparin
The correct answer is intravenous unfractionated heparin. This patient presents with an acute deep vein thrombosis and requires immediate systemic anticoagulation. A critical factor in selecting her therapy is her severe chronic kidney disease (eGFR 11 mL/min/1.73 m²). Unfractionated heparin is primarily metabolized by the reticuloendothelial system and macrophages. Its clearance is relatively unaffected by renal function, making it the safest and most appropriate initial choice for patients with an eGFR < 30 mL/min/1.73 m².

Step-by-Step Solution

1
Diagnose the acute condition requiring treatment.
The patient has an acute deep vein thrombosis (DVT) in the right femoral vein.
Compression ultrasonography confirmed the presence of the clot, establishing the need for immediate systemic anticoagulation.
2
Identify patient-specific modifiers that influence pharmacotherapy selection.
The patient has severe chronic kidney disease (CKD stage 5) with an eGFR of 11 mL/min/1.73 m².
Anticoagulants have varying degrees of renal clearance, and severe renal impairment significantly alters their safety profiles and contraindications.
3
Select the appropriate anticoagulant based on the patient's renal function.
Intravenous unfractionated heparin is selected as the initial therapy.
Unfractionated heparin is cleared by the reticuloendothelial system and does not pose an accumulation risk in severe renal failure, unlike low-molecular-weight heparins, fondaparinux, and most direct oral anticoagulants.

Key Concept

In patients with severe renal impairment (eGFR < 30 mL/min/1.73 m²), intravenous unfractionated heparin is the preferred initial anticoagulant for acute venous thromboembolism because it is primarily cleared by the reticuloendothelial system, avoiding the toxic drug accumulation seen with renally cleared agents.
Question 655Question →

Emergency medical services bring a 23-year-old woman to the resuscitation bay for rapid-onset throat swelling, voice changes, and difficulty swallowing that began two hours after a routine tooth extraction. She denies any new medications, food exposures, or known allergies. Her medical history is notable for three emergency department visits over the last four years for severe, colicky abdominal pain that was evaluated with computed tomography; each time, she was diagnosed with non-specific enteritis and symptoms resolved spontaneously within 48 hours. Her family history reveals that her father died suddenly of respiratory failure at age 35. On presentation, her blood pressure is 115/75 mm Hg, pulse is 102/min, and respirations are 24/min. Physical examination demonstrates massive non-pitting edema of the lips, tongue, and oropharynx. Urticaria and pruritus are completely absent. Stridor is audible. Intramuscular epinephrine, intravenous diphenhydramine, and intravenous methylprednisolone are administered immediately. Re-evaluation 30 minutes later reveals no improvement in her airway swelling. Which of the following is the primary molecular target of the most appropriate directed pharmacotherapy for this patient's current condition?

Show answer & explanation

Answer: Bradykinin B2 receptor

Answer

Bradykinin B2 receptor
The correct answer is the Bradykinin B2 receptor. This patient's presentation of trauma-induced angioedema without urticaria, history of recurrent abdominal pain, family history of sudden airway compromise, and lack of response to standard anaphylaxis therapy is classic for Hereditary Angioedema (HAE). HAE is caused by a deficiency in C1 esterase inhibitor, leading to unregulated activation of plasma kallikrein and massive overproduction of bradykinin. Bradykinin acts primarily on the B2 receptor to cause profound vasodilation and increased vascular permeability. Acute, life-threatening attacks require directed therapy to halt this cascade, commonly achieved with icatibant (a highly specific bradykinin B2 receptor antagonist), ecallantide (a kallikrein inhibitor), or C1-INH replacement. Therefore, the bradykinin B2 receptor is the precise molecular target among the choices provided.

Step-by-Step Solution

1
Analyze the clinical presentation to establish a diagnosis.
The combination of isolated angioedema triggered by minor trauma (tooth extraction), absence of urticaria/pruritus, recurrent unexplained abdominal pain (intestinal edema), positive family history of asphyxiation, and failure to respond to epinephrine and antihistamines strongly points to Hereditary Angioedema (HAE).
Differentiating bradykinin-mediated angioedema from histamine-mediated (allergic) anaphylaxis is critical, as their pathophysiologic mechanisms and acute treatments are entirely different.
2
Determine the pathophysiologic mechanism of the disease.
HAE is an autosomal dominant disorder caused by a deficiency or dysfunction of C1 esterase inhibitor (C1-INH).
Understanding the underlying defect allows for targeted pharmacologic intervention.
3
Trace the biochemical pathway resulting from the defect.
C1-INH normally inhibits both the classical complement pathway (C1r/C1s) and the contact-kinin system (Factor XIIa and plasma kallikrein). Uninhibited plasma kallikrein cleaves high-molecular-weight kininogen into bradykinin.
Excess bradykinin is the direct molecular culprit causing the severe vasodilation and vascular permeability seen in HAE.
4
Identify the target of the required acute pharmacotherapy.
Acute airway-threatening HAE attacks must be treated by interrupting the kinin cascade. This is achieved using a bradykinin B2 receptor antagonist (icatibant), a plasma kallikrein inhibitor (ecallantide), or purified C1-INH concentrate.
The question asks for the primary molecular target of the most appropriate directed pharmacotherapy, making the bradykinin B2 receptor the correct choice.

Key Concept

Hereditary angioedema is a bradykinin-mediated process unresponsive to epinephrine, antihistamines, and glucocorticoids; acute airway attacks require targeted therapies such as bradykinin B2 receptor antagonists (icatibant), kallikrein inhibitors (ecallantide), or C1 inhibitor concentrate.
Question 656Question →

A 34-year-old woman is evaluated in the preoperative clinic prior to a scheduled elective cholecystectomy for symptomatic cholelithiasis. She has no significant past medical history and takes no medications. She has never undergone surgery, but she reports having two uncomplicated vaginal deliveries and no history of excessive bleeding following previous dental extractions.

Preoperative laboratory results show:

Hemoglobin: 13.5 g/dL
Platelet count: 245,000/mm³
Prothrombin time (PT): 12 seconds (normal: 11–14 sec)
Activated partial thromboplastin time (aPTT): 62 seconds (normal: 25–35 sec)
Liver function tests are within normal limits.

Which of the following is the most appropriate next step in laboratory evaluation?

Show answer & explanation

Answer: 1:1 Mixing study with normal plasma

Answer

The most appropriate next step is to perform a 1:1 mixing study with normal plasma to determine if the prolonged aPTT is due to a factor deficiency or an inhibitor.
The correct next step is a 1:1 mixing study. This patient presents with an isolated prolongation of the activated partial thromboplastin time (aPTT) and an entirely negative clinical bleeding history. The differential diagnosis for an isolated aPTT prolongation includes intrinsic factor deficiencies (Factors VIII, IX, XI, XII) or the presence of a circulating inhibitor (most commonly a lupus anticoagulant). A 1:1 mixing study combines the patient's plasma with normal pooled plasma. If the aPTT corrects, a factor deficiency is present. If the aPTT remains prolonged, an inhibitor is present. Given her lack of bleeding symptoms, a lupus anticoagulant (which paradoxically causes thrombosis in vivo but prolongs the aPTT in vitro) or Factor XII deficiency (which does not cause clinical bleeding) are the most probable underlying etiologies. The mixing study is the mandatory algorithmic gateway to determine which specific subsequent assays to order.

Step-by-Step Solution

1
Analyze the patient's clinical presentation and bleeding history.
The patient is completely asymptomatic with a negative bleeding history, having tolerated significant hemostatic challenges (deliveries, dental extractions) without issue.
A negative clinical bleeding history helps rule out severe congenital bleeding diatheses and points toward an in-vitro laboratory phenomenon or a non-hemorrhagic condition.
2
Interpret the preoperative laboratory results.
The patient has an isolated, significantly prolonged aPTT. PT, platelet count, and hemoglobin are completely normal.
An isolated prolonged aPTT indicates an issue specifically within the intrinsic or common pathways of the coagulation cascade.
3
Identify the standard diagnostic algorithm for an isolated prolonged aPTT.
The established initial step for evaluating an unexplained prolonged aPTT is a 1:1 mixing study with normal pooled plasma.
The mixing study broadly categorizes the etiology. If the aPTT corrects, it indicates a factor deficiency (the normal plasma supplies the missing factors). If it fails to correct, it indicates the presence of a circulating inhibitor (which inhibits the factors in the normal plasma as well).

Key Concept

The initial laboratory evaluation of an isolated prolonged aPTT requires a 1:1 mixing study to differentiate between coagulation factor deficiencies and circulating inhibitors before ordering specific confirmatory assays.
Question 657Question →

A 45-year-old woman presents to the clinic complaining of generalized fatigue and weakness for the past 3 months. She reports having heavy menstrual periods lasting 7 to 8 days each month. Vital signs are within normal limits. Physical examination reveals pale conjunctivae.

Laboratory results are as follows:

TestResultReference Range
Hemoglobin9.2 g/dL12.0-15.5 g/dL
Mean corpuscular volume (MCV)72 fL80-100 fL
Serum iron25 µg/dL60-170 µg/dL
Total iron-binding capacity (TIBC)480 µg/dL240-450 µg/dL
Serum ferritin8 ng/mL12-150 ng/mL

Which of the following is the most likely diagnosis based on these laboratory findings?

Show answer & explanation

Answer: Iron deficiency anemia

Answer

Iron deficiency anemia
The correct answer is iron deficiency anemia. The laboratory results show a microcytic anemia (MCV < 80 fL) accompanied by a classic iron deficiency profile. In iron deficiency, total body iron stores are depleted, leading to a characteristically low serum ferritin (the most sensitive and specific marker). In response to low iron stores, the liver increases the production of transferrin, which is reflected as an elevated total iron-binding capacity (TIBC). The combination of low serum iron, high TIBC, and low ferritin in a menstruating woman with fatigue definitively confirms this diagnosis.

Step-by-Step Solution

1
Evaluate the complete blood count (CBC) to classify the anemia.
The patient has a low hemoglobin (9.2 g/dL) and a low MCV (72 fL), indicating a microcytic anemia.
Classifying the anemia by MCV significantly narrows the differential diagnosis.
2
Analyze the iron study panel to determine the specific etiology of the microcytic anemia.
The results show low serum iron, high total iron-binding capacity (TIBC), and low serum ferritin.
Iron studies differentiate between the primary causes of microcytosis (iron deficiency, thalassemia, anemia of chronic disease, sideroblastic anemia).
3
Synthesize the laboratory data with the patient's clinical history.
The diagnostic lab profile perfectly aligns with the history of chronic blood loss from heavy menstruation.
Clinical context confirms the etiology of the laboratory derangements.

Key Concept

Interpreting iron studies to diagnose the specific cause of a microcytic anemia.
Question 658Question →

A 42-year-old man comes to the physician reporting a 4-month history of worsening fatigue, unintentional 5-kg (11-lb) weight loss, and a strong craving for salty foods. His blood pressure is 92/58 mm Hg. Physical examination reveals generalized hyperpigmentation, particularly prominent over his knuckles and palmar creases. A diagnosis of primary adrenal insufficiency is suspected. Arrange the following laboratory tests in the most appropriate chronological sequence for the diagnostic workup, from initial biochemical evaluation to confirmation of the most common etiology.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: 1) Measurement of morning serum cortisol and plasma corticotropin (ACTH) levels, 2) Cosyntropin (synthetic ACTH) stimulation test, 3) Measurement of serum 21-hydroxylase antibodies.
The correct sequence follows the standard diagnostic algorithm for suspected primary adrenal insufficiency: initial biochemical assessment, followed by dynamic confirmatory testing, and finally etiological determination. Morning (8 AM) serum cortisol and plasma ACTH levels are the first-line screening tests. A low cortisol with a high ACTH points to primary adrenal insufficiency. The cosyntropin (synthetic ACTH) stimulation test is then used to definitively confirm the diagnosis by demonstrating an absent or blunted cortisol response. Finally, once the diagnosis is biochemically established, 21-hydroxylase antibody testing is indicated to identify autoimmune adrenalitis, which accounts for the vast majority of primary cases.

Step-by-Step Solution

1
Identify the suspected diagnosis based on the clinical vignette.
The patient's fatigue, weight loss, salt craving, hypotension, and generalized hyperpigmentation strongly suggest primary adrenal insufficiency (Addison's disease).
Recognizing the clinical syndrome determines the specific diagnostic laboratory algorithm to follow.
2
Determine the first step in the diagnostic testing algorithm.
The initial evaluation requires simultaneous measurement of morning (8 AM) serum cortisol and plasma ACTH.
A low morning cortisol paired with an elevated ACTH provides immediate evidence for primary adrenal insufficiency before proceeding to more complex dynamic testing.
3
Identify the appropriate confirmatory test.
The high-dose cosyntropin (synthetic ACTH) stimulation test is the standard confirmatory test.
It assesses the adrenal gland's maximal capacity to produce cortisol and definitively confirms the diagnosis if the initial screening is equivocal or requires verification.
4
Determine the final test to establish the underlying etiology.
Measurement of 21-hydroxylase antibodies is the final step in this sequence.
Once the functional diagnosis is confirmed, establishing the underlying cause is necessary for management. Autoimmune adrenalitis is the most common cause of primary adrenal insufficiency and is identified by these antibodies.

Key Concept

Diagnostic sequencing for primary adrenal insufficiency begins with initial morning cortisol and ACTH levels, proceeds to a cosyntropin stimulation test for confirmation, and concludes with 21-hydroxylase antibody testing to determine the etiology.
Question 659Question →

A 54-year-old man comes to the primary care clinic complaining of progressive fatigue, joint pain in his hands, and erectile dysfunction over the past 6 months. His past medical history is significant for type 2 diabetes mellitus diagnosed 8 months ago, which has been difficult to control despite adherence to metformin therapy. He does not use tobacco, alcohol, or illicit drugs. His family history is notable for a father who died of liver cirrhosis of unknown etiology. Vital signs are within normal limits. Physical examination reveals hepatomegaly and a distinct grayish-bronze hyperpigmentation of the skin, most prominent on his forearms and face. Joint examination shows tenderness and mild bony enlargement of the second and third metacarpophalangeal joints bilaterally. Genitourinary examination reveals bilateral testicular atrophy. Which of the following is the most appropriate next step in laboratory evaluation?

Show answer & explanation

Answer: Serum transferrin saturation and ferritin levels

Answer

The most appropriate next step is to order serum transferrin saturation and ferritin levels.
The patient presents with a classic constellation of symptoms for hereditary hemochromatosis, including new-onset diabetes mellitus, hepatomegaly, skin hyperpigmentation (often referred to as 'bronze diabetes'), arthropathy characteristically affecting the second and third metacarpophalangeal joints, and secondary hypogonadism (manifesting as erectile dysfunction and testicular atrophy). Hereditary hemochromatosis is characterized by excessive intestinal iron absorption leading to iron deposition and fibrosis in target organs such as the liver, pancreas, anterior pituitary, and joints. The most appropriate initial step in laboratory evaluation is screening for biochemical iron overload by measuring serum transferrin saturation and serum ferritin levels. A transferrin saturation greater than 45% is highly sensitive and warrants subsequent confirmatory testing.

Step-by-Step Solution

1
Analyze the patient's comprehensive clinical presentation.
The combination of new-onset diabetes mellitus, hepatomegaly, bronze skin hyperpigmentation, second and third metacarpophalangeal joint arthropathy, and secondary hypogonadism points to a systemic metabolic disorder.
Identifying the underlying unifying syndrome prevents premature closure on individual, isolated symptoms.
2
Identify the most likely diagnosis based on the clinical syndrome and family history.
The clinical picture and a family history of unexplained liver cirrhosis strongly suggest hereditary hemochromatosis.
Hereditary hemochromatosis typically becomes symptomatic in men in their 40s or 50s as iron progressively accumulates in target organs over decades.
3
Determine the most appropriate initial laboratory diagnostic test for the suspected condition.
The initial evaluation requires non-invasive screening for iron overload using serum transferrin saturation and serum ferritin levels.
Highly sensitive, low-cost screening tests must logically precede expensive or invasive confirmatory tests in the diagnostic sequence.

Key Concept

Hereditary hemochromatosis presents systemically with hepatomegaly, skin hyperpigmentation, diabetes mellitus, specific arthropathy, and hypogonadism; the initial diagnostic step is screening with serum iron studies prior to genetic confirmation.
Question 660Question →

A 68-year-old man presents to the outpatient clinic with a 4-week history of progressively worsening yellowing of his skin and eyes, generalized pruritus, and a 15-lb (6.8 kg) unintentional weight loss. He reports that his urine has become dark brown and his stools are pale and malodorous. He has no significant past medical history and takes no medications. Vital signs are within normal limits. Physical examination reveals marked scleral icterus and jaundice. Abdominal examination is notable for a palpable, non-tender, rounded mass in the right upper quadrant.

Laboratory studies show:
Total bilirubin: 14.2 mg/dL
Direct bilirubin: 11.5 mg/dL
Alkaline phosphatase: 520 U/L
Aspartate aminotransferase (AST): 85 U/L
Alanine aminotransferase (ALT): 92 U/L
Lipase: 45 U/L

A transabdominal right upper quadrant ultrasound is performed, revealing a significantly dilated common bile duct measuring 16 mm, intrahepatic biliary ductal dilation, and a markedly distended gallbladder without evidence of gallstones. A vague, hypoechoic region is noted near the head of the pancreas.

Which of the following is the most appropriate next step in the diagnostic imaging evaluation of this patient?

Show answer & explanation

Answer: Multiphasic contrast-enhanced computed tomography of the abdomen

Answer

Multiphasic contrast-enhanced computed tomography of the abdomen
The patient's presentation of painless jaundice, weight loss, and a palpable, non-tender gallbladder (Courvoisier sign) is highly suspicious for a malignant biliary obstruction, specifically pancreatic head adenocarcinoma. While the initial ultrasound confirmed extra- and intra-hepatic biliary dilation without stones, the next essential step in the diagnostic evaluation is a multiphasic contrast-enhanced CT (pancreatic protocol). This imaging modality provides high-resolution, multiphase (arterial, pancreatic, and portal venous) cross-sectional images. These are absolutely critical for detecting the primary mass, determining its relationship to surrounding vasculature (superior mesenteric artery/vein, celiac axis), and identifying distant metastases (liver, peritoneum). Accurate non-invasive staging must be completed before any invasive procedures are performed to determine surgical resectability.

Step-by-Step Solution

1
Analyze the clinical presentation and physical examination findings.
The patient has painless jaundice, weight loss, and a palpable, non-tender gallbladder (Courvoisier sign).
These findings are highly specific for a malignant biliary obstruction distal to the cystic duct, most commonly pancreatic head adenocarcinoma.
2
Interpret the initial imaging results.
Right upper quadrant ultrasound confirms a dilated biliary tree and distended gallbladder without stones, alongside a vague pancreatic mass.
Ultrasound is the correct initial test to rule out choledocholithiasis, but it lacks the resolution to adequately stage a suspected pancreatic malignancy.
3
Determine the optimal next step in the diagnostic sequence.
Select multiphasic contrast-enhanced CT (pancreatic protocol).
Before any invasive procedures (like ERCP or EUS) are performed, accurate non-invasive cross-sectional staging must be obtained to determine tumor size, vascular involvement, and the presence of distant metastases, which ultimately dictates surgical resectability.

Key Concept

In patients with suspected pancreatic cancer based on initial ultrasound, multiphasic contrast-enhanced CT of the abdomen must be performed prior to any invasive biliary procedures (ERCP or EUS) to ensure accurate staging and avoid imaging artifacts.
Estimated Time:1m 30s
PreviousPage 33 / 237Next